Novo-Peridol en es it fr

Novo-Peridol Brand names, Novo-Peridol Analogs

Novo-Peridol Brand Names Mixture

  • No information avaliable

Novo-Peridol Chemical_Formula


Novo-Peridol RX_link

Novo-Peridol fda sheet

Novo-Peridol FDA

Novo-Peridol msds (material safety sheet)

Novo-Peridol MSDS

Novo-Peridol Synthesis Reference

P. A. J. Janssen, Belg. pat. 577,977 (1959), C.A. 54, 4630c (1960); idem, Brit. pat. 895,309 corresp to U.S. pat. 3,438,991 (1962, 1969 to Janssen).

Novo-Peridol Molecular Weight

375.864 g/mol

Novo-Peridol Melting Point

151.5 oC

Novo-Peridol H2O Solubility

14 mg/L

Novo-Peridol State


Novo-Peridol LogP


Novo-Peridol Dosage Forms

Injection; Oral solution; Tablet

Novo-Peridol Indication

For the treatment of schizophrenic patients who require prolonged parenteral antipsychotic therapy also used in Tourette's syndrome and Severe hyperactivity.

Novo-Peridol Pharmacology

Haloperidol is a psychotropic agent indicated for the treatment of schizophrenia. It also exerts sedative and antiemetic activity. Haloperidol has actions at all levels of the central nervous system-primarily at subcortical levels-as well as on multiple organ systems. Haloperidol has strong antiadrenergic and weaker peripheral anticholinergic activity; ganglionic blocking action is relatively slight. It also possesses slight antihistaminic and antiserotonin activity.

Novo-Peridol Absorption


Novo-Peridol side effects and Toxicity

LD50=165 mg/kg (rats, oral)

Novo-Peridol Patient Information


Novo-Peridol Organisms Affected

Humans and other mammals